Skip to content

Prevention of Postoperative Atrial Fibrillation

A New Therapeutic Strategy to Reduce the Incidence of Postoperative Atrial Fibrillation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01742039
Enrollment
160
Registered
2012-12-05
Start date
2008-07-31
Completion date
2011-06-30
Last updated
2023-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Atrial Fibrillation

Brief summary

The primary aim of this study is to determine the safest and most effective therapeutic strategy to decrease the incidence of postoperative atrial fibrillation following cardiac surgery in an era with shorter ICU and hospital length of stay. A secondary goal is to evaluate the length of hospital stay associated with each treatment strategy.

Interventions

None listed

Sponsors

George Washington University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* age \> or = to 18 years * sinus rhythm * undergoing either coronary artery bypass graft surgery (CABG), valvular heart surgery or a combined procedure

Exclusion criteria

* received a class-I or class-III antiarrhythmic agent in the past six months * had second or third degree heart block * had a resting heart rate of less than 50 beats per minute * had a systolic blood pressure less than 100 mmHg * had severe asthma or severe chronic obstructive pulmonary disease * had uncontrolled heart failure * had a serum aspartate aminotransferase or alanine aminotransferase concentration greater than four times the upper limit of normal

Design outcomes

Primary

MeasureTime frameDescription
occurrence of atrial fibrillationpostoperative day 0-day of discharge (an average of 5 days)The primary endpoint of this study was also the occurrence of atrial fibrillation for any length of time requiring treatment as a result of symptoms or hemodynamic compromise.

Secondary

MeasureTime frameDescription
length of stayparticipants will be followed for the duration of hospital stay, an expected average of 5 daysThe secondary endpoint was the length of hospital stay after surgery.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026